Abiopharma

News list

Langsam Jeffrey 🟢 acquired 70.3K shares of Oncology Institute, Inc. (TOI) Transaction Date: Mar 27, 2026 | Filing ID: 000449

Full text

News bot April 2, 2026, 1 a.m.
🔍 Langsam Jeffrey (Executive)

Company: Oncology Institute, Inc. (TOI)

Report Date: 2026-03-27
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 70,270
Detailed Transactions and Holdings:
- Acquired 70,270 shares of Common Stock (Direct)
  Date: 2026-03-27 | Code: A | equity_swap_involved: 0 | shares_owned_after: 127,650.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Represents RSU awards with 1/4 of the RSUs vesting on the first anniversary of the Vesting Commencement Date, with the remaining RSUs vesting in three equal annual installments beginning on the first anniversary of the Vesting Commencement Date, with all RSUs becoming vested on the fourth anniversary of the Vesting Commencement Date, subject to continued service with the Company through such vesting dates.